Table 2.
Absolute values (average ± standard deviation) for the different parameters analyzed in thymic cell control cultures (without experimental drugs). These averages were used for normalization of data in Figs. 2, 3 and 4. All measured values are from day 14 except for anti-AChR production which are from day 11. N/A: not analyzed; Irrad: irradiated.
| Patient | IgG [ng/ml/day] | Anti-AChR [nM/day] | Plasma cells [N°/well] |
Cell numbers / well / 1000 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Non-Irrad. | Irrad. | Non-Irrad. | Irrad. | Non-Irrad. | Irrad. | Total viable (PI−) | CD3+ T-cells | CD20+ B-cells | |
| MG-1 | 77.9 ± 19.6 | 65.9 ± 62.6 | 2.8 ± 0.7 | 2.0 ± 0.9 | 96 ± 17 | 89 ± 8 | 28.12 ± 13.67 | 18.28 ± 8.88 | 2.43 ± 1.13 |
| MG-2 | 191.9 ± 35.3 | 17.8 ± 12.8 | 1.2 ± 0.6 | ~0.2 | 236 ± 16 | 16 ± 8 | 78.07 ± 22.68 | 57.42 ± 18.66 | 6.04 ± 0.80 |
| MG-3 | 57.7 ± 6.0 | 4.0 ± 1.5 | 1.3 ± 0.2 | <0.1 | 61 ± 37 | 1 ± 1 | 37.35 ± 12.98 | 20.91 ± 7.74 | 3.26 ± 1.11 |
| MG-4 | 298.0 ± 75.0 | N/A | 1.0 ± 0.1 | N/A | 84 ± 53 | N/A | 147.01 ± 13.48 | 64.33 ± 3.85 | 4.08 ± 0.82 |
| MG-5 | 83.8 ± 18.0 | 14.6 ± 7.2 | 1.1 ± 0.4 | <0.1 | 165 ± 31 | 21 ± 6 | 130.53 ± 19.47 | 85.86 ± 16.29 | 4.81 ± 1.57 |
| MG-6 | 9.0 ± 2.8 | 27.7 ± 10.4 | <0.1 | <0.1 | N/A | 21 ± 12 | 26.12 ± 9.94 | 17.54 ± 6.28 | 0.32 ± 0.20 |
| MG-7 | 325.0 ± 158.6 | N/A | <0.1 | N/A | N/A | N/A | N/A | N/A | N/A |
| MG-8 | 43.8 ± 17.6 | N/A | ~0.2 | N/A | 157 ± 68 | N/A | N/A | N/A | N/A |
| MG-9 | N/A | N/A | N/A | N/A | N/A | N/A | 16.94 ± 2.73 | N/A | N/A |
| MG-10 | 42.3 ± 10.6 | N/A | 1.3 ± 0.4 | N/A | N/A | N/A | N/A | N/A | N/A |